12 results on '"Vrazhnov, Denis A."'
Search Results
2. Types of spectroscopy and microscopy techniques for cancer diagnosis: a review
- Author
-
Kaniyala Melanthota, Sindhoora, Kistenev, Yury V., Borisova, Ekaterina, Ivanov, Deyan, Zakharova, Olga, Boyko, Andrey, Vrazhnov, Denis, Gopal, Dharshini, Chakrabarti, Shweta, K, Shama Prasada, and Mazumder, Nirmal
- Published
- 2022
- Full Text
- View/download PDF
3. Predictive models for COVID-19 detection using routine blood tests and machine learning
- Author
-
Kistenev, Yury V., Vrazhnov, Denis A., Shnaider, Ekaterina E., and Zuhayri, Hala
- Published
- 2022
- Full Text
- View/download PDF
4. Terahertz Time-Domain Spectroscopy of Blood Serum for Differentiation of Glioblastoma and Traumatic Brain Injury.
- Author
-
Vrazhnov, Denis A., Ovchinnikova, Daria A., Kabanova, Tatiana V., Paulish, Andrey G., Kistenev, Yury V., Nikolaev, Nazar A., and Cherkasova, Olga P.
- Subjects
TERAHERTZ time-domain spectroscopy ,BRAIN injuries ,BLOOD serum analysis ,DIMENSIONAL reduction algorithms ,GLIOBLASTOMA multiforme ,SERUM - Abstract
The possibility of the differentiation of glioblastoma from traumatic brain injury through blood serum analysis by terahertz time-domain spectroscopy and machine learning was studied using a small animal model. Samples of a culture medium and a U87 human glioblastoma cell suspension in the culture medium were injected into the subcortical brain structures of groups of mice referred to as the culture medium injection groups and glioblastoma groups, accordingly. Blood serum samples were collected in the first, second, and third weeks after the injection, and their terahertz transmission spectra were measured. The injection caused acute inflammation in the brain during the first week, so the culture medium injection group in the first week of the experiment corresponded to a traumatic brain injury state. In the third week of the experiment, acute inflammation practically disappeared in the culture medium injection groups. At the same time, the glioblastoma group subjected to a U87 human glioblastoma cell injection had the largest tumor size. The THz spectra were analyzed using two dimensionality reduction algorithms (principal component analysis and t-distributed Stochastic Neighbor Embedding) and three classification algorithms (Support Vector Machine, Random Forest, and Extreme Gradient Boosting Machine). Constructed prediction data models were verified using 10-fold cross-validation, the receiver operational characteristic curve, and a corresponding area under the curve analysis. The proposed machine learning pipeline allowed for distinguishing the traumatic brain injury group from the glioblastoma group with 95% sensitivity, 100% specificity, and 97% accuracy with the Extreme Gradient Boosting Machine. The most informative features for these groups' differentiation were 0.37, 0.40, 0.55, 0.60, 0.70, and 0.90 THz. Thus, an analysis of mouse blood serum using terahertz time-domain spectroscopy and machine learning makes it possible to differentiate glioblastoma from traumatic brain injury. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Terahertz Time-Domain Spectroscopy of Glioma Patient Blood Plasma: Diagnosis and Treatment.
- Author
-
Cherkasova, Olga, Vrazhnov, Denis, Knyazkova, Anastasia, Konnikova, Maria, Stupak, Evgeny, Glotov, Vadim, Stupak, Vyacheslav, Nikolaev, Nazar, Paulish, Andrey, Peng, Yan, Kistenev, Yury, and Shkurinov, Alexander
- Subjects
TERAHERTZ time-domain spectroscopy ,BLOOD plasma ,CENTRAL nervous system tumors ,GLIOMAS ,MACHINE learning ,SUPPORT vector machines - Abstract
Gliomas, one of the most severe malignant tumors of the central nervous system, have a high mortality rate and an increased risk of recurrence. Therefore, early glioma diagnosis and the control of treatment have great significance. The blood plasma samples of glioma patients, patients with skull craniectomy defects, and healthy donors were studied using terahertz time-domain spectroscopy (THz-TDS). An analysis of experimental THz data was performed by machine learning (ML). The ML pipeline included (i) THz spectra smoothing using the Savitzky–Golay filter, (ii) dimension reduction with principal component analysis and t-distribution stochastic neighborhood embedding methods; (iii) data separability analyzed using Support Vector Machine (SVM), Random Forest (RF), and Extreme Gradient Boosting (XGBoost). The ML models' performance was evaluated by a k-fold cross validation technique using ROC-AUC, sensitivity, and specificity metrics. It was shown that tree-based ensemble methods work more accurately than SVM. RF and XGBoost provided a better differentiation of the group of patients with glioma from healthy donors and patients with skull craniectomy defects. THz-TDS combined with ML was shown to make it possible to separate the blood plasma of patients before and after tumor removal surgery (AUC = 0.92). Thus, the applicability of THz-TDS and ML for the diagnosis of glioma and treatment monitoring has been shown. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Discovering Glioma Tissue through Its Biomarkers' Detection in Blood by Raman Spectroscopy and Machine Learning.
- Author
-
Vrazhnov, Denis, Mankova, Anna, Stupak, Evgeny, Kistenev, Yury, Shkurinov, Alexander, and Cherkasova, Olga
- Subjects
- *
GLIOMAS , *MACHINE learning , *GLIOBLASTOMA multiforme , *BLOOD serum analysis , *BRAIN tumors , *SPECTRAL line broadening , *RAMAN spectroscopy - Abstract
The most commonly occurring malignant brain tumors are gliomas, and among them is glioblastoma multiforme. The main idea of the paper is to estimate dependency between glioma tissue and blood serum biomarkers using Raman spectroscopy. We used the most common model of human glioma when continuous cell lines, such as U87, derived from primary human tumor cells, are transplanted intracranially into the mouse brain. We studied the separability of the experimental and control groups by machine learning methods and discovered the most informative Raman spectral bands. During the glioblastoma development, an increase in the contribution of lactate, tryptophan, fatty acids, and lipids in dried blood serum Raman spectra were observed. This overlaps with analogous results of glioma tissues from direct Raman spectroscopy studies. A non-linear relationship between specific Raman spectral lines and tumor size was discovered. Therefore, the analysis of blood serum can track the change in the state of brain tissues during the glioma development. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Analysis of Mouse Blood Serum in the Dynamics of U87 Glioblastoma by Terahertz Spectroscopy and Machine Learning.
- Author
-
Vrazhnov, Denis, Knyazkova, Anastasia, Konnikova, Maria, Shevelev, Oleg, Razumov, Ivan, Zavjalov, Evgeny, Kistenev, Yury, Shkurinov, Alexander, and Cherkasova, Olga
- Subjects
BLOOD serum analysis ,MACHINE learning ,TERAHERTZ time-domain spectroscopy ,GLIOBLASTOMA multiforme ,TERAHERTZ spectroscopy ,PRINCIPAL components analysis ,MICE - Abstract
In this research, an experimental U87 glioblastoma small animal model was studied. The association between glioblastoma stages and the spectral patterns of mouse blood serum measured in the terahertz range was analyzed by terahertz time-domain spectroscopy (THz-TDS) and machine learning. The THz spectra preprocessing included (i) smoothing using the Savitsky–Golay filter, (ii) outlier removing using isolation forest (IF), and (iii) Z-score normalization. The sequential informative feature-selection approach was developed using a combination of principal component analysis (PCA) and a support vector machine (SVM) model. The predictive data model was created using SVM with a linear kernel. This model was tested using k-fold cross-validation. Achieved prediction accuracy, sensitivity, specificity were over 90%. Also, a relation was established between tumor size and the THz spectral profile of blood serum samples. Thereby, the possibility of detecting glioma stages using blood serum spectral patterns in the terahertz range was demonstrated. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Application of Artificial Intelligence Methods Depending on the Tasks Solved during COVID-19 Pandemic.
- Author
-
Tolmachev, Ivan, Kaverina, Irina, Vrazhnov, Denis, Starikov, Iurii, Starikova, Elena, and Kostuchenko, Evgeny
- Subjects
COVID-19 pandemic ,ARTIFICIAL intelligence ,MEDICAL personnel ,DECISION support systems ,MATHEMATICAL models - Abstract
Health systems challenges that emerged during the COVID-19 pandemic, such as a lack of resources and medical staff, are forcing solutions which optimize healthcare performance. One of the solutions is the development of clinical decision support systems (CDSS) based on artificial intelligence (AI). We classified AI-based clinical decision-supporting systems used during the pandemic and evaluated the mathematical algorithms present in these systems. Materials and methods: we searched for articles relevant to the aim of the study in the Scopus publication database. Results: depending on the purpose of the development a clinical decision support system based on artificial intelligence during pandemic, we identified three groups of tasks: organizational, scientific and diagnostic. Tasks such as predicting of pandemic parameters, searching of analogies in pandemic progression, prioritization of patients, use of telemedicine are solved for the purposes of healthcare organization. Artificial intelligence in drugs and vaccine development, alongside personalized treatment programs, apply to new scientific knowledge acquisition. Diagnostic tasks include the development of mathematical models for assessing COVID-19 outcomes, prediction of disease severity, analysis of factors influencing COVID-19 complications. Conclusion: artificial intelligence methods can be effectively implemented for decision support systems in solving tasks that face healthcare during pandemic. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Terahertz spectroscopy of diabetic and non-diabetic human blood plasma pellets.
- Author
-
Lykina, Anastasiya A., Nazarov, Maksim M., Konnikova, Maria R., Mustafin, Ilia A., Vaks, Vladimir L., Anfertev, Vladimir A., Domracheva, Elena G., Chernyaeva, Mariya B., Kistenev, Yuri V., Vrazhnov, Denis A., Prischepa, Vladimir V., Kononova, Yulia A., Korolev, Dmitry V., Cherkasova, Olga P., Shkurinov, Alexander P., Babenko, Alina Y., and Smolyanskaya, Olga A.
- Subjects
BLOOD plasma ,TYPE 2 diabetes ,TERAHERTZ spectroscopy ,SUPERVISED learning ,REFRACTIVE index ,MACHINE learning - Abstract
Significance: The creation of fundamentally new approaches to storing various biomaterial and estimation parameters, without irreversible loss of any biomaterial, is a pressing challenge in clinical practice. We present a technology for studying samples of diabetic and non-diabetic human blood plasma in the terahertz (THz) frequency range. Aim: The main idea of our study is to propose a method for diagnosis and storing the samples of diabetic and non-diabetic human blood plasma and to study these samples in the THz frequency range. Approach: Venous blood from patients with type 2 diabetes mellitus and conditionally healthy participants was collected. To limit the impact of water in the THz spectra, lyophilization of liquid samples and their pressing into a pellet were performed. These pellets were analyzed using THz time-domain spectroscopy. The differentiation between the THz spectral data was conducted using multivariate statistics to classify non-diabetic and diabetic groups' spectra. Results: We present the density-normalized absorption and refractive index for diabetic and non-diabetic pellets in the range 0.2 to 1.4 THz. Over the entire THz frequency range, the normalized index of refraction of diabetes pellets exceeds this indicator of non-diabetic pellet on average by 9% to 12%. The non-diabetic and diabetic groups of the THz spectra are spatially separated in the principal component space. Conclusion: We illustrate the potential ability in clinical medicine to construct a predictive rule by supervised learning algorithms after collecting enough experimental data. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Diagnosis of Glioma Molecular Markers by Terahertz Technologies.
- Author
-
Cherkasova, Olga, Peng, Yan, Konnikova, Maria, Kistenev, Yuri, Shi, Chenjun, Vrazhnov, Denis, Shevelev, Oleg, Zavjalov, Evgeny, Kuznetsov, Sergei, and Shkurinov, Alexander
- Subjects
TERAHERTZ technology ,NANOTECHNOLOGY ,MOLECULAR diagnosis ,MACHINE learning ,GLIOMAS ,DIAGNOSIS - Abstract
This review considers glioma molecular markers in brain tissues and body fluids, shows the pathways of their formation, and describes traditional methods of analysis. The most important optical properties of glioma markers in the terahertz (THz) frequency range are also presented. New metamaterial-based technologies for molecular marker detection at THz frequencies are discussed. A variety of machine learning methods, which allow the marker detection sensitivity and differentiation of healthy and tumor tissues to be improved with the aid of THz tools, are considered. The actual results on the application of THz techniques in the intraoperative diagnosis of brain gliomas are shown. THz technologies' potential in molecular marker detection and defining the boundaries of the glioma's tissue is discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Malignant and benign thyroid nodule differentiation through the analysis of blood plasma with terahertz spectroscopy.
- Author
-
Konnikova MR, Cherkasova OP, Nazarov MM, Vrazhnov DA, Kistenev YV, Titov SE, Kopeikina EV, Shevchenko SP, and Shkurinov AP
- Abstract
The liquid and lyophilized blood plasma of patients with benign or malignant thyroid nodules and healthy individuals were studied by terahertz (THz) time-domain spectroscopy and machine learning. The blood plasma samples from malignant nodule patients were shown to have higher absorption. The glucose concentration and miRNA-146b level were correlated with the sample's absorption at 1 THz. A two-stage ensemble algorithm was proposed for the THz spectra analysis. The first stage was based on the Support Vector Machine with a linear kernel to separate healthy and thyroid nodule participants. The second stage included additional data preprocessing by Ornstein-Uhlenbeck kernel Principal Component Analysis to separate benign and malignant thyroid nodule participants. Thus, the distinction of malignant and benign thyroid nodule patients through their lyophilized blood plasma analysis by terahertz time-domain spectroscopy and machine learning was demonstrated., Competing Interests: The authors declare that there are no conflicts of interest., (© 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement.)
- Published
- 2021
- Full Text
- View/download PDF
12. Application of multiphoton imaging and machine learning to lymphedema tissue analysis.
- Author
-
Kistenev YV, Nikolaev VV, Kurochkina OS, Borisov AV, Vrazhnov DA, and Sandykova EA
- Abstract
The results of in-vivo two-photon imaging of lymphedema tissue are presented. The study involved 36 image samples from II stage lymphedema patients and 42 image samples from healthy volunteers. The papillary layer of the skin with a penetration depth of about 100 μm was examined. Both the collagen network disorganization and increase of the collagen/elastin ratio in lymphedema tissue, characterizing the severity of fibrosis, was observed. Various methods of image characterization, including edge detectors, a histogram of oriented gradients method, and a predictive model for diagnosis using machine learning, were used. The classification by "ensemble learning" provided 96% accuracy in validating the data from the testing set., Competing Interests: The authors declare that there are no conflicts of interest related to this article.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.